A detailed history of Boston Partners transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Boston Partners holds 469 shares of TMO stock, worth $243,335. This represents 0.0% of its overall portfolio holdings.

Number of Shares
469
Previous 472 0.64%
Holding current value
$243,335
Previous $261,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$531.86 - $624.21 $1,595 - $1,872
-3 Reduced 0.64%
469 $290,000
Q2 2024

Aug 13, 2024

SELL
$541.52 - $599.02 $180,867 - $200,072
-334 Reduced 41.44%
472 $261,000
Q1 2024

May 13, 2024

SELL
$528.82 - $599.43 $37,017 - $41,960
-70 Reduced 7.99%
806 $468,000
Q4 2023

Feb 07, 2024

SELL
$431.41 - $532.94 $408,976 - $505,227
-948 Reduced 51.97%
876 $464,000
Q2 2023

Aug 10, 2023

SELL
$508.46 - $591.13 $433,716 - $504,233
-853 Reduced 31.86%
1,824 $951,000
Q1 2023

May 09, 2023

SELL
$535.0 - $604.82 $3.4 Million - $3.84 Million
-6,353 Reduced 70.35%
2,677 $1.54 Million
Q4 2022

Feb 07, 2023

SELL
$484.71 - $571.37 $1.19 Million - $1.4 Million
-2,447 Reduced 21.32%
9,030 $4.97 Million
Q3 2022

Nov 09, 2022

SELL
$507.19 - $604.49 $2.16 Million - $2.57 Million
-4,254 Reduced 27.04%
11,477 $5.82 Million
Q2 2022

Aug 10, 2022

BUY
$500.9 - $612.21 $1.33 Million - $1.62 Million
2,653 Added 20.29%
15,731 $8.55 Million
Q1 2022

May 10, 2022

BUY
$524.0 - $644.92 $1.4 Million - $1.72 Million
2,669 Added 25.64%
13,078 $7.73 Million
Q4 2021

Feb 04, 2022

SELL
$569.0 - $667.24 $1.42 Million - $1.67 Million
-2,500 Reduced 19.37%
10,409 $6.95 Million
Q3 2021

Nov 05, 2021

SELL
$509.53 - $609.78 $2.95 Million - $3.53 Million
-5,782 Reduced 30.93%
12,909 $7.38 Million
Q2 2021

Aug 12, 2021

BUY
$441.0 - $508.24 $8.24 Million - $9.5 Million
18,691 New
18,691 $9.43 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $203B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Boston Partners Portfolio

Follow Boston Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.